$VANI 3 SEC Filings

Filed On	Filing
26 Jun 2026	Form 3: Moretti August J, Director No securities owned
17 Jun 2025	Form 3: Baldor Anthony, Chief Financial Officer No securities owned
11 Mar 2024	Form 3: Bradbury Daniel, Director Holds 0 shares of Common Stock
25 Apr 2023	Form 3: Bolck Joachim Eberhard, 10% owner Holds 528,265 shares of Common Stock
31 Aug 2022	Form 3: Mendelsohn Adam, Director Holds 0 shares of Common Stock
31 Aug 2022	Form 3: Le Truc, COO Holds 0 shares of Common Stock
31 Aug 2022	Form 3: Makes Brigid, CFO Holds 0 shares of Common Stock
31 Aug 2022	Form 3: Dwyer Donald, Chief Business Officer Holds 0 shares of Common Stock
31 Aug 2022	Form 3: Porter Lisa Ellen, Chief Medical Officer Holds 0 shares of Common Stock
27 Apr 2021	Form 3: Baker Wilford Dean, Director Holds 0 shares of Common Stock
22 Apr 2021	Form 3: Larson Alexandra L.p., Director Holds 0 shares of Common Stock
08 Apr 2021	Form 3: Dunbar Scott, Acting CEO Holds 2,383 shares of Common Stock
30 Sep 2020	Form 3: Randolph Edward David, Vice President-Operations Holds 2 shares of Common Stock
14 Sep 2020	Form 3: Sedo Edward Jonathon, Controller
02 Oct 2019	Form 3: Dorn Jessy Dana, VP-Clin & Scientific Affairs Holds 1,458 shares of Common Stock
10 Sep 2018	Form 3: Ryan William Patrick, Chief Operating Officer Holds 0 shares of Common Stock
27 Mar 2018	Form 3: Blake John T, Chief Financial Officer Holds 0 shares of Common Stock
22 May 2017	Form 3: Alfred E. Mann Living Trust, 10% owner and 1 other Holds 5,260,272 shares of Common Stock
08 Mar 2017	Form 3: Jacques David Murray, VP - Research Development Holds 0 shares of Common Stock
05 Apr 2016	Form 3: Okland Stephen D, Commercial V.P., North America Holds 0 shares of Common Stock

Comments